Exploring Convergence Science Worldwide


Convergence thinking & policy








  • Breakthroughs in Spatiotemporal Gene Control in Organoids

    Feb 27, 2024, 14:19 PM by Arnaud Legrand
    In recent years, the scientific community has made significant strides in the field of organoid research, a domain that sits at the confluence of stem cell science, developmental biology, and biomedical engineering. Organoids, essentially miniaturised and simplified versions of organs produced in vitro, offer a promising avenue for understanding human development, disease modelling, and potentially paving the way for personalised medicine. Yet, despite their potential, one of the enduring challenges has been manipulating these organoids to mimic the complex spatial and temporal patterns of gene expression observed in natural organ development.
    Full story
  • Beyond Traditional Models: Human Lung Alveolus Chip in Radiation Research

    Oct 31, 2023, 14:18 PM by Arnaud Legrand
    Radiation-induced lung injury (RILI) is a severe and life-threatening condition that arises from exposure to high doses of ionizing radiation. Such exposures can occur during radiological disasters, nuclear incidents, or as an unintended side effect of radiation therapy for cancer. Understanding the intricacies of RILI is essential to improve the outcomes for cancer patients undergoing radiation therapy.
    Full story
  • Drug Delivery: An Inspiration from Cephalopods

    Oct 10, 2023, 16:31 PM by Arnaud Legrand
    Biopharmaceuticals, encompassing proteins and peptides, have significantly impacted the treatment of various diseases like diabetes, heart disorders, and cancer. However, a major drawback is that these drugs mostly need to be injected due to their large size and instability. Over the years, attempts to create oral forms of some of these drugs have faced challenges, particularly in getting them absorbed efficiently in the body.
    Full story
  • Enhancing Biointerfaces for Advanced Bioelectronic Devices

    Aug 31, 2023, 09:46 AM by Arnaud Legrand
    The successful integration of electronic devices with delicate biotissues relies on seamless interfacing. A recent article titled "Bioadhesive polymer semiconductors and transistors for intimate biointerfaces" addresses this challenge by introducing a novel bioadhesive polymer semiconductor. This promises to improve the way we use bioelectronic devices for real-time biological signal measurement and health monitoring.
    Full story
  • Whole Slide Image Registration for Spatial Omics Studies

    Aug 18, 2023, 12:18 PM by Arnaud Legrand
    As the field of spatial omics gains traction, the need for highly multiplexed images is on the rise. However, creating such images poses significant challenges, including cost, technical expertise, and limitations in available technology. One solution is the registration of collections of whole slide images (WSI) to generate spatially aligned datasets. This opens doors for advanced spatial analyses and holds the potential to transform our understanding of cellular interactions and tissue structure within the tumour microenvironment.
    Full story
  • Decoding the Molecular Symphony of Cancer

    Aug 18, 2023, 11:49 AM by Arnaud Legrand
    Cancer, a complex and multifaceted disease, is often initiated by genetic mutations that act as driving forces for tumour growth. These genetic changes, known as oncogenic driver events, are central to our understanding of cancer development. However, the intricate mechanisms through which these drivers exert their influence on the cellular machinery remain a puzzle yet to be fully solved. In this study, researchers have employed a comprehensive approach, merging genomics and proteomics, to shed light on the connections between oncogenic drivers and the functional states of cancer cells.
    Full story
  • Mammography Screening Gets an Artificial Intelligence Upgrade

    Aug 18, 2023, 11:21 AM by Arnaud Legrand
    In a clinical study, scientists have assessed the power of artificial intelligence (AI) to transform the landscape of mammography screening. The Mammography Screening with Artificial Intelligence trial (MASAI) introduces an innovative AI-supported screen-reading protocol, revolutionising how radiologists interpret mammograms. Unlike previous retrospective studies, MASAI is the first-of-its-kind randomised trial to investigate the clinical safety and effectiveness of AI integration in mammography screening.
    Full story
  • Bacteria as DNA Detectives

    Aug 17, 2023, 17:16 PM by Arnaud Legrand
    In a remarkable fusion of biology and technology, scientists have achieved a significant breakthrough by engineering bacteria to act as precision DNA detectives. The latest research by Cooper et al. introduces a concept where bacteria, specifically Acinetobacter baylyi, are transformed into dynamic biosensors capable of detecting specific mutations in human DNA. What makes this achievement truly remarkable is that these bacteria, known for their nonpathogenic nature and natural competence for DNA uptake, have been harnessed to spot cancer-associated mutations, offering a potential pathway for early cancer detection and targeted treatment.
    Full story
  • Bridging Philosophy and Science for Advancing Cancer Research

    Aug 11, 2023, 22:01 PM by Arnaud Legrand
    Cancer, with its intricate and diverse processes across various scales and fields, demands a multidisciplinary effort. To tackle this complexity, a consortium of experts in cancer and philosophy has proposed an innovative approach that melds scientific experimentation with philosophical inquiry. By intertwining applied sciences, including clinical and experimental research, with conceptual and theoretical insights, this review aims to foster a more integrated understanding of cancer. Through a comprehensive exploration of six key themes, such as mutations, tumour microenvironment, and immune system dynamics, the researchers exemplify how philosophical methods can augment scientific comprehension.
    Full story
  • Enhancing Cancer Diagnostics with CRISPR-Cas Technology

    Aug 11, 2023, 18:16 PM by Arnaud Legrand
    This study introduces a new method that combines CRISPR-Cas gene-editing technology and molecular barcoding for improved cancer detection. By stabilising DNA to act as molecular barcodes, researchers triggered diagnostic signals in response to disease-related changes. CRISPR nucleases were then employed to detect these signals, offering a specific readout for diagnostics. This approach could lead to non-invasive and rapid cancer detection, showcasing the potential of converging scientific fields for significant healthcare advancements.
    Full story
  • Decoding Tumor Evolution and Treatment Response

    Aug 11, 2023, 18:05 PM by Arnaud Legrand
    Collaborating across London and Milan, a groundbreaking study delves into immune selection's role in tumour development and checkpoint inhibitor effectiveness. By analysing immune dN/dS – a mutation ratio within immune-interacting regions – two tumour categories emerged: immune-edited (shedding antigenic mutations) and immune-escaped (masking antigenicity). CD8 T cell infiltration linked to immune-edited tumours, while immune-escaped ones responded better to immunotherapy. Nivolumab treatment targeted neoantigens in nonimmune-edited patients. This study emphasizes understanding tumour evolution for improved personalised medicine, suggesting new approaches for refining cancer treatment strategies.
    Full story
  • Researchers Develop Graphene Biosensors for Early Pancreatic Cancer Detection

    Aug 11, 2023, 11:29 AM by Arnaud Legrand
    Imperial College London researchers have developed graphene biosensors that could revolutionize early disease detection. These biosensors utilize graphene field effect transistors (GFETs) to rapidly and accurately identify pancreatic cancer, offering a portable and versatile diagnostic tool. By detecting cancer-specific exosomes, the GFET biosensor platform shows promising potential for enhancing healthcare and improving patient outcomes.
    Full story
  • Advancing Cancer Immunotherapy through Convergence

    Aug 11, 2023, 11:19 AM by Arnaud Legrand
    Researchers from MIT's Koch Institute for Integrative Cancer Research have unveiled a pioneering approach in cancer immunotherapy. By combining CD4+ T cells, STING signaling, and immune checkpoint blockade (ICB), the study offers a novel strategy to eradicate tumors. This innovative synergy not only highlights the potential of CD4+ T cells but also addresses STING deficiency, paving the way for more effective and personalized cancer treatments.
    Full story
  • Revolutionising Gut Health Monitoring with Miniaturised Biosensors

    Aug 11, 2023, 10:04 AM by Arnaud Legrand
    A pioneering convergence of genetics, engineering, and electronics has created a miniaturised biosensor. Nitric oxide and hydrogen sulfide, elusive inflammation signals, are detected by engineered probiotic bacteria linked to electronic circuits. This innovation offers real-time insight into gut health, promising early disease detection and personalised care.
    Full story